Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes

Alsufyani, ShahadAli

doi:10.4103/jfmpc.jfmpc_115_21

Cited by 8 publications

(9 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the current study, compared to persons with other diseases, individuals with diabetes were more willing to be vaccinated (54.3% of patients with diabetes), which is consistent with three previous studies that found persons with diabetes were more likely to be vaccinated. In previous Saudi research evaluating influenza vaccination among individuals with Type 2 diabetes, Abha observed a 61% vaccination uptake rate [30], 47.8% in Riyadh [31], and 43.5% in Taif [32]. These findings were considerable when compared tonational levels and those of other Gulf countries [12].…”

Section: Discussionmentioning

confidence: 93%

Seasonal Influenza Vaccination among Patients with Chronic Diseases: Prevalence, Acceptability, and Hesitation

HAIFA MOHAMMED AL NAFEA, Ph.D.

2024

The Medical Journal of Cairo University

View full text Add to dashboard Cite

Background: Seasonal influenza vaccination (SIV) is an essential public health measure for preventing the spread of influenza viruses and mitigating the adverse health effects associated with them. Vaccination is particularly crucial for individuals with Chronic diseases (CDs), as they are at a higher risk of developing complications from the influenza virus. Aim of Study:This study aimed to determine the prevalence of influenza vaccine (IV) uptake among CD patients, the factors influencing it, and what the main reasons were for those who chose to receive the IV and those who did not. Material and Methods:A secondary analysis was conducted on 241 participants with CDs who were aged 18 years or older based on a previous cross-sectional study.Results: A total of 43.2% of the participants received the IV during flu sessions in 2023. SIV was significantly associated with the source of information regarding vaccination. There was a higher probability (OR=1.49) of people not taking the IV when they received information from an untrusted source. Patients with immune diseases were more likely not to choose to take the vaccine (OR=3.04), while patients with diabetes were less likely to not take it (OR=0.64). Participants with CDs were more likely to choose to take the influenza vaccine due to encouragement from their healthcare providers than to their current health. In contrast, many CD patients refused vaccination without an apparent reason. Conclusion:Patients with CDs had low influenza immunization rates. Primary healthcare practitioners should implement new and more effective methods of educating susceptible populations to increase influenza vaccination rates.

show abstract

Section: Discussionmentioning

confidence: 93%

Seasonal Influenza Vaccination among Patients with Chronic Diseases: Prevalence, Acceptability, and Hesitation

HAIFA MOHAMMED AL NAFEA, Ph.D.

2024

The Medical Journal of Cairo University

View full text Add to dashboard Cite

show abstract

“…It was also determined that 5.9% of those aged 65 years and over, 5.6% of those with diabetes, 5.5% of those with asthma, and 5.1% of those with COPD/chronic bronchitis/emphysema got the flu vaccine in the last year. In patients with type 2 diabetes, 43.5% of the patients took the seasonal flu vaccine ( 13 ). In the U.S., 37.1% of adults took the flu vaccine during the 2017–2018 flu season ( 14 ).…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Preventive Health Practices in Turkey

Çakır¹

2023

ijph

View full text Add to dashboard Cite

Background: Although preventive health practices are extremely effective in preventing diseases and mortality, there is still a need to determine the frequency of these practices in different countries and improve these rates. The aim of this study was to evaluate preventive health practices in Turkey. Methods: The study was designed as a cross-sectional research. The study was conducted by utilizing the “Turkey Health Survey 2019” microdata set from the Turkish Statistical Institute. The data of 17,084 people aged 15 years and over were evaluated. Results: Approximately 54.4% of the participants were women, 24.5% were 15–29 years old, and 21.0% were 60 years of age or older. Approximately 51.2% of the participants stated that their general health status as good. 2.3% of the participants had taken the flu vaccine in the last year, 38% of people aged 50–70 years had undergone a fecal occult blood test in the last 5 years, 32% of women aged 40–69 years had undergone mammography/breast X-ray in the last 2 years, and 44% of women aged 30–65 years had undergone a cervical swab test in the last 5 years. Conclusion: Although the rate of public participation in cancer screenings in Turkey is considerable, the data show that the rates should be further increased. In contrast, flu vaccination frequency is considerably low. To increase the frequency of preventive health practices, Turkish public should be informed about these practices, where they can be performed, and their importance.

show abstract

“…Similarly, in a study that assessed the uptake of the vaccine among children in Saudi Arabia by asking 399 parents, only 37.6% of the children were indicated to have ever received the vaccine [ 15 ]. Finally, among the studies that assessed influenza vaccination among patients affected with type 2 diabetes, the uptake of the vaccine was reported to reach 61% in Abha [ 7 ], 47.8% in Riyadh [ 8 ], and 43.5% in Taif [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

Assessment of Influenza Vaccine Uptake According to the Presence of a Chronic Disease

et al. 2023

View full text Add to dashboard Cite

Patients diagnosed with a chronic disease are at higher risk of influenza complications. This investigation aimed to estimate influenza vaccine uptake rates among healthy subjects and patients with chronic diseases, and to identify barriers to and facilitators of its uptake. This study was a cross-sectional investigation that targeted the general population in the Jazan region of Saudi Arabia. Data were collected via online platforms between October and November 2022. Data were collected via a self-administered questionnaire that assessed the demographics, influenza vaccine uptake, and factors associated with the uptake. A chi-squared test was used to investigate factors associated with the uptake of the influenza vaccine. A total of 825 adult subjects participated in the current investigation. The proportion of male participants was higher (61%) compared to females (38%). The mean age of the participants was 36, with a standard deviation of 10.5. Nearly 30% of the sample reported being diagnosed with a chronic disease. Among the recruited sample, 576 (69.8%) reported having ever received the influenza vaccine, and only 222 participants (27%) indicated that they receive the influenza vaccination annually. Only history of being diagnosed with a chronic disease was statistically associated with the history of ever receiving the influenza vaccine (p < 0.001). Among the 249 participants with a chronic disease, only 103 (41.4%) ever received the influenza vaccine and only 43 (17.3%) of them received the vaccine annually. The main barrier to the uptake was fear of side effects due to the vaccination. A minority of the participants indicated that they were motivated by a healthcare worker to have the vaccine. This suggests an area for further investigation to assess the involvement of healthcare workers in motivating their patients with chronic diseases to have the vaccine.

show abstract

Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes

Cited by 8 publications

References 42 publications

Seasonal Influenza Vaccination among Patients with Chronic Diseases: Prevalence, Acceptability, and Hesitation

Seasonal Influenza Vaccination among Patients with Chronic Diseases: Prevalence, Acceptability, and Hesitation

Evaluation of Preventive Health Practices in Turkey

Assessment of Influenza Vaccine Uptake According to the Presence of a Chronic Disease

Contact Info

Product

Resources

About